Mega Genomics Ltd.

  • Market Cap: Micro Cap
  • Industry: Medical/Nursing Services
  • ISIN: KYG5960G1047
HKD
7.20
-0.05 (-0.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
167.19
169.46
285.86
228.36
140.27
231.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
167.19
169.46
285.86
228.36
140.27
231.58
Raw Material Cost
74.09
85.23
89.44
72.54
54.91
137.26
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
56.54
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.24
0.84
8.33
18.60
22.21
22.45
Selling and Distribution Expenses
41.12
87.30
43.91
25.96
22.14
51.57
Other Expenses
-3.31
2.18
0.40
-1.41
-1.77
-1.54
Total Expenditure (Excl Depreciation)
139.93
195.14
145.65
102.99
81.52
195.88
Operating Profit (PBDIT) excl Other Income
27.3
-25.7
140.2
125.39999999999999
58.7
35.699999999999996
Other Income
13.96
19.66
10.05
2.71
7.23
1.35
Operating Profit (PBDIT)
57.93
11.75
164.11
140.90
81.56
51.97
Interest
1.24
0.84
8.33
18.60
22.21
22.45
Exceptional Items
0.00
-18.06
-23.51
0.11
0.00
0.00
Gross Profit (PBDT)
93.10
84.23
196.42
155.82
85.35
94.32
Depreciation
16.71
17.77
16.72
15.77
15.94
15.37
Profit Before Tax
39.98
-24.91
115.56
106.64
43.42
14.15
Tax
6.79
-4.42
20.33
17.76
9.75
-11.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
33.19
-20.49
95.23
88.88
33.67
26.11
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
33.19
-20.49
95.23
88.88
33.67
26.11
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.19
-20.49
95.23
88.88
33.67
26.11
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
709.96
693.85
849.55
209.14
-3.02
-66.78
Earnings per share (EPS)
0.16
-0.1
0.48
0.0
0.0
0.0
Diluted Earnings per share
0.16
-0.1
0.48
0.0
0.0
0.0
Operating Profit Margin (Excl OI)
16.3%
-15.15%
48.05%
53.61%
41.63%
15.22%
Gross Profit Margin
33.91%
-4.21%
46.27%
53.61%
42.32%
12.75%
PAT Margin
19.85%
-12.09%
33.31%
38.92%
24.0%
11.27%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is -1.36% vs -40.71% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is 261.95% vs -121.53% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is 656.96% vs -105.13% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 50.00% vs -90.36% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has improved from Dec 2022

Compare Annual Results Of Mega Genomics Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
167.19
1,963.87
-1,796.68
-91.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
167.19
1,963.87
-1,796.68
-91.49%
Raw Material Cost
74.09
895.82
-821.73
-91.73%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
56.54
893.85
-837.31
-93.67%
Power Cost
0
0
0.00
Manufacturing Expenses
1.24
59.85
-58.61
-97.93%
Selling and Distribution Expenses
41.12
1,533.81
-1,492.69
-97.32%
Other Expenses
-3.31
-92.13
88.82
96.41%
Total Expenditure (Excl Depreciation)
139.93
2,461.98
-2,322.05
-94.32%
Operating Profit (PBDIT) excl Other Income
27.26
-498.12
525.38
105.47%
Other Income
13.96
-65.55
79.51
121.30%
Operating Profit (PBDIT)
57.93
-192.58
250.51
130.08%
Interest
1.24
59.85
-58.61
-97.93%
Exceptional Items
0.00
-24.23
24.23
100.00%
Gross Profit (PBDT)
93.10
1,068.05
-974.95
-91.28%
Depreciation
16.71
370.00
-353.29
-95.48%
Profit Before Tax
39.98
-646.67
686.65
106.18%
Tax
6.79
-42.58
49.37
115.95%
Provisions and contingencies
0
0
0.00
Profit After Tax
33.19
-594.34
627.53
105.58%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
33.19
-594.34
627.53
105.58%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-0.32
0.32
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.19
-594.66
627.85
105.58%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
709.96
1,037.76
-327.80
-31.59%
Earnings per share (EPS)
0.16
-1.20
1.36
113.33%
Diluted Earnings per share
0.16
-1.20
1.36
113.33%
Operating Profit Margin (Excl OI)
16.30%
-25.31%
0.00
41.61%
Gross Profit Margin
33.91%
-14.09%
0.00
48.00%
PAT Margin
19.85%
-30.26%
0.00
50.11%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 16.72 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -1.36% vs -40.71% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 3.32 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 261.95% vs -121.53% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.40 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 656.96% vs -105.13% in Dec 2022

Annual - Interest
Interest 0.12 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 50.00% vs -90.36% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.30%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has improved from Dec 2022